MII PR MTB Immunohistochemistry - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Resource Profile: MII PR MTB Immunohistochemistry - Examples

Active as of 2026-09-15

Examples for the mii-pr-mtb-immunohistochemistry Profile.

PatientKimMusterperson-MolecularPathologyInterpret-0a-Her2neu

PatientKimMusterperson-MolecularPathologyObservation-0a-Her2neu

PatientKimMusterperson-MolecularPathologyObservation-0b-Folat-Ra

PatientKimMusterperson-MolecularPathologyObservation-0c-Trop2

PatientKimMusterperson-MolecularPathologyObservation-1-CA125

PatientKimMusterperson-MolecularPathologyObservation-2-Pax8

PatientKimMusterperson-MolecularPathologyObservation-3-WT1

PatientKimMusterperson-MolecularPathologyObservation-4-ER

PatientKimMusterperson-MolecularPathologyObservation-5-PR

PatientKimMusterperson-MolecularPathologyObservation-6-p53

PatientKimMusterperson-MolecularPathologyObservation-7-p53

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-15
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.